Samsung Biologics to attend BIO USA for 14th year, focusing on 'Innovation Driven by Mission'

Samsung Biologics announced its participation in the Bio International Convention (BIO USA), marking its 14th consecutive year at the prestigious event. This year's convention, themed 'Innovation Driven by Mission,' is scheduled to be held in San Diego, California, from June 22 to 25.

BIO USA is recognized as one of the world's largest biotechnology trade shows, attracting over 20,000 pharmaceutical and biotech industry professionals, as well as life science researchers. The convention serves as a critical platform for fostering collaborations, discussing technology transfers, and exploring investment opportunities within the global biopharmaceutical landscape.

Samsung Biologics will operate a 140-square-meter standalone booth at the event. The company is expected to showcase its advanced capabilities and services in contract development and manufacturing organization (CDMO) solutions. This consistent presence at BIO USA underscores Samsung Biologics' commitment to global partnerships and its strategic position within the rapidly evolving biotechnology sector.

The company's long-standing participation highlights its dedication to engaging with international partners and staying at the forefront of industry trends. Attendees can anticipate discussions on cutting-edge technologies, potential business development, and the future direction of biopharmaceutical innovation.